Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Intestinal research

Showing results (301-310 of 835) with videos related to

Pageof 84
Sort By:
Intestinal Research|April 8, 2020
Safety of tumor necrosis factor inhibitor use in patients with concomitant malignancyHiep Phan, Rick A Weideman, Daisha J Cipher, et al.
Intestinal Research|April 1, 2020
Risk Factors Associated with Impaired Ovarian Reserve in Young Women of Reproductive Age with Crohn's DiseaseYue Zhao, Baili Chen, Yao He, et al.
Intestinal Research|January 18, 2026
Comments on "Week 2 remission with vedolizumab as a predictor of long-term remission in patients with ulcerative colitis: a multicenter, retrospective, observational study"Philippe Pinton
Intestinal Research|February 9, 2026
KASID and Intestinal Research journal: a central academic hub for research of intestinal diseases in the Asia-Pacific regionJae Hee Cheon, Hye Kyung Hyun, You Sun Kim, et al.
Intestinal Research|February 9, 2026
Interpreting vedolizumab persistence: lessons from real-world trajectories in ulcerative colitisJung Min Moon
Intestinal Research|February 9, 2026
Correction: Gut, bone, and muscle: the triad of osteosarcopenia in inflammatory bowel diseaseShilpa Sharma
Intestinal Research|February 7, 2025
Elucidating the association between nonalcoholic fatty liver disease and incidence of inflammatory bowel disease: a focus on systemic inflammationSihyun Kim, Jong Pil Im
Intestinal Research|November 6, 2025
Comments on "Role of 5-aminosalicylic acid in ulcerative colitis management in 8 Asian territories: a physician survey"Tsutomu Nishida, Takahiro Amano, Naoto Osugi, et al.
Intestinal Research|June 9, 2025
Upadacitinib and vedolizumab combination therapy for the management of refractory ulcerative colitis and Crohn's diseaseRobert Gilmore, Amrutha Murali, Amirah Etchegaray, et al.
Intestinal Research|December 25, 2025
The JAK attack: transforming the management of ulcerative colitis in IndiaArshdeep Singh, Arshia Bhardwaj, Vandana Midha, et al.
Pageof 84

Showing results (301-310 of 835) with videos related to

Sort By:
Pageof 84
Intestinal Research|April 8, 2020
Safety of tumor necrosis factor inhibitor use in patients with concomitant malignancyHiep Phan, Rick A Weideman, Daisha J Cipher, et al.
Intestinal Research|April 1, 2020
Risk Factors Associated with Impaired Ovarian Reserve in Young Women of Reproductive Age with Crohn's DiseaseYue Zhao, Baili Chen, Yao He, et al.
Intestinal Research|January 18, 2026
Comments on "Week 2 remission with vedolizumab as a predictor of long-term remission in patients with ulcerative colitis: a multicenter, retrospective, observational study"Philippe Pinton
Intestinal Research|February 9, 2026
KASID and Intestinal Research journal: a central academic hub for research of intestinal diseases in the Asia-Pacific regionJae Hee Cheon, Hye Kyung Hyun, You Sun Kim, et al.
Intestinal Research|February 9, 2026
Interpreting vedolizumab persistence: lessons from real-world trajectories in ulcerative colitisJung Min Moon
Intestinal Research|February 9, 2026
Correction: Gut, bone, and muscle: the triad of osteosarcopenia in inflammatory bowel diseaseShilpa Sharma
Intestinal Research|February 7, 2025
Elucidating the association between nonalcoholic fatty liver disease and incidence of inflammatory bowel disease: a focus on systemic inflammationSihyun Kim, Jong Pil Im
Intestinal Research|November 6, 2025
Comments on "Role of 5-aminosalicylic acid in ulcerative colitis management in 8 Asian territories: a physician survey"Tsutomu Nishida, Takahiro Amano, Naoto Osugi, et al.
Intestinal Research|June 9, 2025
Upadacitinib and vedolizumab combination therapy for the management of refractory ulcerative colitis and Crohn's diseaseRobert Gilmore, Amrutha Murali, Amirah Etchegaray, et al.
Intestinal Research|December 25, 2025
The JAK attack: transforming the management of ulcerative colitis in IndiaArshdeep Singh, Arshia Bhardwaj, Vandana Midha, et al.
Pageof 84